Development of a biological ventricular assist device - Preliminary data from a small animal model

Article; Proceedings Paper

关键词: EMBRYONIC STEM-CELLS;    ACUTE MYOCARDIAL-INFARCTION;    ENGINEERED HEART-TISSUE;    MYOBLAST TRANSPLANTATION;    CARDIAC REPAIR;    RAT HEARTS;    IN-VIVO;    GRAFTS;    CARDIOMYOCYTES;    DIFFERENTIATION;   

DOI  :  10.1161/CIRCULATIONAHA.106.679688

来源: SCIE

【 摘 要 】

Background - Engineered heart tissue (EHT) can be generated from cardiomyocytes and extracellular matrix proteins and used to repair local heart muscle defects in vivo. Here, we hypothesized that pouch-like heart muscle constructs can be generated by using a novel EHT-casting technology and applied as heart-embracing cardiac grafts in vivo. Methods and Results - Pouch-like EHTs (inner/outer diameter: 10/12 mm) can be generated mainly from neonatal rat heart cells, collagen type I, and serum containing culture medium. They contain a dense network of connexin 43 interconnected cardiomyocytes and an endo-/epicardial surface lining composed of prolylhydroxylase positive cells. Pouch-like EHTs beat spontaneously and show contractile properties of native heart muscle including positive inotropic responses to calcium and isoprenaline. First implantation studies indicate that pouch-like EHTs can be slipped over uninjured adult rat hearts to completely cover the left and right ventricles. Fourteen days after implantation, EHT-grafts stably covered the epicardial surface of the respective hearts. Engrafted EHTs were composed of matrix and differentiated cardiac muscle as well as newly formed vessels which were partly donor-derived. Conclusions - Pouch-like EHTs can be generated with structural and functional properties of native myocardium. Implantation studies demonstrated their applicability as cardiac muscle grafts, setting the stage for an evaluation of EHT-pouches as biological ventricular assist devices in vivo.

【 授权许可】

Free